Skip to main content
Clinical Trials/NCT06350721
NCT06350721
Completed
Not Applicable

Feasibility, Usability and Safety of the Vestibular Rehabilitation Using the Immersive Virtual Reality Software DizzyVR

Universidad Loyola Andalucia1 site in 1 country10 target enrollmentOctober 1, 2024

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Vestibular Disorder
Sponsor
Universidad Loyola Andalucia
Enrollment
10
Locations
1
Primary Endpoint
Adherence rate
Status
Completed
Last Updated
7 months ago

Overview

Brief Summary

The main goals of this pilot study is to assess the feasibility, usability, satisfaction and safety of the immersive virtual reality system called DizzyVR in participants diagnosed with a vestibular disorder. In addition, it aims to collect preliminary data about clinical effectiveness. The main questions it aims to answer are:

  • To assess the feasibility, usability and safety of the system DizzyVR for the vestibular rehabilitation in participants with vestibular disorders.
  • To detect and record possible adverse events due to the use of DizzyVR.
  • To examine the degree of adherence of the participants to the intervention.
  • To know the average success rate of the different games in each session.
  • To evaluate the average difficulty levels overcome throughout the intervention.
  • To know the usability and satisfaction with the system reported by participants and therapists.
  • To assess preliminary efficacy data on the impact of this new vestibular rehabilitation system on dizziness, gait speed, balance confidence and gait stability.

Participants will receive the vestibular rehabilitation based on the novel immersive virtual systema, DizzyVR.

Detailed Description

Once the patient is received in the physiotherapy area of the Vertigo Unit, the researchers will proceed to provide the informational sheet and informed consent, as well as verbally explain the project. After the informed consent is signed, the researchers will collect all descriptive variables, as well as the baseline score of the DHI questionnaire (T0). During the course of the research, the researchers will daily record participants' attendance, the overall percentage of correct answers in each session, the occurrence of undesired effects, and the score of the Simulator Sickness Questionnaire (T1). In the final physiotherapy session (T2), each participant will re-evaluate the DHI questionnaire, as well as the perceived usability questionnaire of the system (SUS) and the virtual systems satisfaction evaluation questionnaire (USEQ). Finally, approximately 15 days after the intervention concludes, participants will be scheduled for in-depth individual perceptions about the system through a semi-structured interview (T3). With the same purpose, after the period of using the DizzyVR system, the researchers will interview the physiotherapists who have participated in this study (T4). Each patient will receive a total of 8 sessions of vestibular rehabilitation with the DizzyVR system. Each session will last for 50 minutes, with a frequency of one session per week. The total duration of the intervention will be 10 weeks, with the initial assessment/T0 taking place in the first week and the final assessment/T2 in the tenth week. Similarly, the total expected participation time for each participant is set at 12 weeks (T3).

Registry
clinicaltrials.gov
Start Date
October 1, 2024
End Date
January 31, 2025
Last Updated
7 months ago
Study Type
Interventional
Study Design
Single Group
Sex
All

Investigators

Sponsor
Universidad Loyola Andalucia
Responsible Party
Principal Investigator
Principal Investigator

Cristina García-Muñoz

Principal investigator

Universidad Loyola Andalucia

Eligibility Criteria

Inclusion Criteria

  • Men or women between the ages of 18 and
  • Confirmed diagnosis of central or peripheral vestibulopathy.
  • Preserved walking ability.
  • Presence of dizziness symptoms as assessed by the Dizziness Handicap Inventory (\> 10 points).

Exclusion Criteria

  • Severe visual impairments.
  • Cognitive impairment (Mini Mental State Examination \< 24).
  • Existence of comorbidities severely affecting postural control and balance.
  • Uncontrolled systemic diseases that contradict physical activity.

Outcomes

Primary Outcomes

Adherence rate

Time Frame: 10 weeks

percentage of completed sessions

Simulator Sickness Questionnaire (SSQ)

Time Frame: 10 weeks

Security of the system

Progression

Time Frame: 10 weeks

Levels of the games accomplished during the sessions.

Success rate

Time Frame: 10 weeks

Mean success rates of the games per session

System Usability Scale (SUS)

Time Frame: 10 weeks

Participants perceived usability of the system.

User Satisfaction Evaluation Questionnaire (USEQ)

Time Frame: 10 weeks

Acceptability of the prototype device/software

Register of risk and number of adverse events experimented by the stakeholders

Time Frame: 10 weeks

Security of the prototype device

Secondary Outcomes

  • Timed Up and Go Test (TUG)(10 weeks)
  • Functional Gait Assessment questionnaire (FGA)(10 weeks)
  • Dizziness Handicap Inventory(10 weeks)
  • Activities-specific Balance Confidence Scale (ABC)(10 weeks)

Study Sites (1)

Loading locations...

Similar Trials